Testimony Wraps Up In Plavix Trial
After about five years spent fighting over the blood-thinner Plavix, three pharmaceutical companies inched closer to a resolution, with the trial over the drug's patent drawing to a close on Thursday....To view the full article, register now.
Already a subscriber? Click here to view full article